Baxter Initiates Voluntary Recall IV Solutions Due to the Potential Presence of Particulate Matter

Baxter International has voluntarily recalled two lots of intravenous (IV) solutions to the hospital/user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to patient administration and there have been no adverse events associated with this issue reported to Baxter.

Injecting a product containing particulate matter, in the absence of in-line filtration, may result in blockage of blood vessels, which can result in stroke, heart attack or damage to other organs such as the kidney or liver. There is also the possibility of allergic reactions, local irritation and inflammation in tissues and organs.

The lots being recalled (P319921 and P327635) were distributed to customers and distributors in the US between 7 October 2014 and 14 July 2015.